Fat dissolving injections and weight loss: correcting a common mix-up

The biggest misconception: cosmetic fat dissolvers do not cause weight loss

Deoxycholic acid injections (sold under brand names like Kybella in the US and Belkyra in some markets) are sometimes called fat dissolving injections in beauty and aesthetics contexts. They destroy fat cell membranes at a very localised injection site. The procedure is used on small areas, most commonly submental fat (beneath the chin), and the clinical evidence supports that narrow application. It is not a weight management treatment. There is no clinical evidence that deoxycholic acid injections produce meaningful reduction in body weight, BMI, or systemic adiposity.

This matters because someone searching for weight loss fat dissolving injections may land on an aesthetics clinic website, see the phrase used interchangeably, and leave with a very distorted picture of what's available. Cosmetic fat dissolvers are not regulated as medicines for obesity in the UK, they are not recommended in NHS or NICE guidance for weight management, and they are entirely separate from the GLP-1 class. Worth knowing before you book anything.

If your goal is measurable, sustained weight reduction rather than sculpting a small area, you're looking at a different category of medicine altogether, and the distinction is not subtle.

What licensed weight loss injections actually do in the body

Wegovy (semaglutide) and Mounjaro (tirzepatide) work through gut-hormone pathways, not by dissolving fat cells locally. Semaglutide is a GLP-1 receptor agonist, it mimics a naturally occurring hormone released after eating, slows gastric emptying, and reduces appetite signals in the brain. Tirzepatide adds a second pathway: it also activates GIP receptors, making it the only dual-agonist weight management medicine currently licensed in the UK.

Neither medicine burns or dissolves fat directly. What they do is shift the body's energy balance by making it easier to eat less without constant hunger. Fat mass falls as a consequence of sustained calorie reduction over months, not through a chemical reaction at a needle site.

You can read more about the biological mechanism and what the trial data show on our page on whether weight loss injections burn fat. The short answer is: not in the way the phrase implies, but the clinical results are real and well-documented. The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported an average weight reduction of around 20–21% at 15mg tirzepatide over 72 weeks in adults with obesity, a figure that exceeds what any cosmetic fat-dissolving treatment has come close to producing across the whole body.

Semaglutide's STEP 1 trial reported around 15% average weight reduction at 2.4mg over 68 weeks, published in the New England Journal of Medicine. These are not aesthetic results. They are changes in bodyweight with measurable effects on blood pressure, blood sugar and cardiovascular risk markers.

Who these medicines are actually licensed for, and what the assessment involves

Both Mounjaro and Wegovy are licensed for adults with a BMI of 30 or above, or a BMI from 27 upward with at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance.

A prescriber doesn't just look at a number on the scale. They review your full medical history, current medicines, any contraindications, and whether either treatment is appropriate given your circumstances. That process can't be shortcut, and reputable services don't try to shortcut it. At nume, a GPhC-registered prescriber reads your consultation the same day; no automated approval, no algorithm making clinical decisions.

People sometimes wonder whether these injections work specifically on belly fat. The evidence on abdominal fat reduction is encouraging (visceral fat (the metabolically active fat around the organs) does reduce with sustained GLP-1 treatment) but the medicine acts systemically, not by targeting one area. That's the opposite of the cosmetic model.

For context on how the wider category of available weight loss injections compare, or if you want an overview of treatment options in general, those pages cover the landscape in more detail. The NHS tirzepatide information page is also a straightforward starting point for understanding what the medicine is and how it works.

A note on cost, timing and where to look

The cost of cosmetic fat-dissolving sessions and the cost of a clinical weight management programme are not remotely comparable, in what they include, what they do, and how prices are structured. Cosmetic clinics often charge per session for a local procedure. Licensed weight management programmes involve ongoing clinical review, prescription, and monitored dose escalation over months.

On the question of what weight loss injections cost in the UK, prices vary by dose, provider and what's included in the fee. A legitimate price always covers a clinical assessment and prescription, not just the medicine. If you're researching options around payday or planning to start in January when motivation tends to spike, it's worth understanding exactly what different services include before comparing figures.

Some searches land on pages about products described as the Santex injection or similar, these are not licensed weight management medicines in the UK, and we'd encourage scepticism toward any injectable product claiming fat-dissolving or weight-loss effects that doesn't sit within the licensed prescribing framework. The MHRA has issued repeated warnings about unlicensed and counterfeit injectable products sold online. Report anything suspicious at the MHRA's Yellow Card scheme.

If you'd like to explore whether Mounjaro or Wegovy might be appropriate for you, check your eligibility with a free consultation, our prescribers can talk through your options without any obligation.